Document Detail


Evaluation of toxicity and single-dose pharmacokinetics of intravenous ursolic acid liposomes in healthy adult volunteers and patients with advanced solid tumors.
MedLine Citation:
PMID:  23134084     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Objective: The purpose of this study was to investigate the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and pharmacokinetics of ursolic acid liposomes (UAL), as a new drug, in healthy adult volunteers and patients with advanced solid tumors. Methods: All subjects received a single-dose of UAL (11, 22, 37, 56, 74, 98, and 130 mg/m(2)) administered as a 4-h intravenous infusion. Toxicity was assessed and plasma samples were analyzed using validated ultra-performance liquid chromatograph/tandem mass spectroscopy method. Results: A total of 63 subjects including 4 patients and 35 healthy adult volunteers for toxicity study and 24 healthy adult volunteers for pharmacokinetic study were enrolled in this trial. The DLT was encountered at 74, 98, and 130 mg/m(2), and consisted of hepatotoxicity and diarrhea. Other adverse events included grade 1 nausea, grade 2 abdominal distention, grade 1 microscopic hematuria, grade 2 elevated serum sodium, grade 1 vascular stimulation, and grade 1 skin rash. The MTD was 98 mg/m(2). The single-dose pharmacokinetic parameters revealed a linear relationship between C(max), AUC(0→24 h), or AUC(0→∞) and escalated doses. Conclusions: The clinical data reported for the first time that UAL had manageable toxicities with MTD of 98 mg/m(2). The DLT were hepatotoxicity and diarrhea. Meanwhile, UAL had a linear pharmacokinetic profile. The registration number of this trial is ChiCTR-ONC-12002385.
Authors:
Xian-Huo Wang; Shi-Yong Zhou; Zheng-Zi Qian; Hui-Lai Zhang; Li-Hua Qiu; Zheng Song; Jing Zhao; Ping Wang; Xi-Shan Hao; Hua-Qing Wang
Related Documents :
18189264 - Efficacy of the pear ester as a monitoring tool for codling moth cydia pomonella (lepid...
23172384 - Different characteristic phenotypes according to antibody in myasthenia gravis.
21753154 - Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (gdc-044...
15778874 - Dronabinol and marijuana in hiv(+) marijuana smokers: acute effects on caloric intake a...
3587644 - Peripheral pharmacokinetics of levodopa in untreated, stable, and fluctuating parkinson...
12768274 - On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensit...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-8
Journal Detail:
Title:  Expert opinion on drug metabolism & toxicology     Volume:  -     ISSN:  1744-7607     ISO Abbreviation:  Expert Opin Drug Metab Toxicol     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101228422     Medline TA:  Expert Opin Drug Metab Toxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Tianjin Medical University, Tianjin Medical University Cancer Hospital and Institute, Sino-US Center for Lymphoma and Leukemia, Department of Lymphoma, Key Laboratory of Cancer Prevention and Therapy , Tiyuanbei, Huanhuxi Road, Hexi District, Tianjin 300060 , China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Non-ketotic hyperglycinaemia; Case Report and Review of Medical Literature.
Next Document:  Responding to the World Report on Disability in Australia: Lessons from collaboration in an urban Ab...